Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma

NCT02814643 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Benralizumab
DRUG: Benralizumab Placebo
DRUG: Seasonal influenza virus vaccine

Sponsor

AstraZeneca